WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, announced today the first U.S. implantation of the Comprehensive® Nano Stemless Shoulder, part of an FDA Investigational Device Exemption (IDE) multi-center prospective clinical study.
Help employers find you! Check out all the jobs and post your resume.
